Sofie (United States) has no DMF, CEP or site registration linked in our records. 42 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Sofie: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/sofie

Overview

Sofie is a pharmaceutical company headquartered in Dulles, United States.

FDA compliance signals

42 FDA enforcement records linked to this company.

  • 4832026-01-15

    Determination need for investigation

  • 4832026-01-15

    Record quality

  • 4832025-10-28

    Adequate controls (general)

  • 4832025-10-28

    Determination need for investigation

  • 4832025-10-28

    Orderly handling, prevention of mix-ups, prevention of contamination

  • 4832025-10-28

    Personnel not qualified

  • 4832025-09-03

    Adequate controls (general)

  • 4832025-08-28

    Equipment procedures

  • 4832025-08-07

    Equipment procedures

  • 4832025-08-07

    Personnel not qualified

  • 4832025-08-07

    Data and documentation review

  • 4832025-07-25

    Conform to specs prior to release

  • 4832025-07-25

    Written QA procedures established, followed

  • 4832024-01-22

    Orderly handling, prevention of mix-ups, prevention of contamination

  • 4832024-01-22

    Personnel not qualified

  • 4832024-01-22

    Adequate controls (general)

  • 4832023-08-11

    Documentation of Non-Conforming Product Investigation

  • 4832023-08-11

    Complaint review

  • 4832023-08-11

    Labeling and product mix-ups

  • 4832023-08-11

    Orderly handling, prevention of mix-ups, prevention of contamination

  • 4832023-01-20

    Written QA procedures established, followed

  • 4832023-01-20

    Equipment

  • 4832023-01-20

    Before implementing new procedure establish and document accuracy etc.

  • 4832023-01-20

    Written complaint procedures

  • 4832023-01-20

    Correction of problems

  • 4832023-01-20

    Adequate controls (general)

  • 4832023-01-20

    Equipment procedures

  • 4832023-01-20

    Determination need for investigation

  • warning_letter2019-10-10

    FDA Warning Letter (drug product)

  • 4832019-04-12

    Analytical methods

  • 4832019-04-12

    Written complaint procedures

  • 4832019-04-12

    Orderly handling, prevention of mix-ups, prevention of contamination

  • 4832019-02-05

    Orderly handling, prevention of mix-ups, prevention of contamination

  • 4832019-02-05

    Initials, signature, date

  • 4832019-02-05

    Personnel not qualified

  • 4832019-02-05

    Final dated signature

  • 4832018-12-03

    Orderly handling, prevention of mix-ups, prevention of contamination

  • 4832018-12-03

    Written QA procedures established, followed

  • 4832018-12-03

    Contamination, chemical or physical change, deterioration

  • 4832016-08-04

    Investigation of nonconforming product

  • 4832016-01-15

    Written QA procedures established, followed

  • warning_letter2008-10-24

    FDA Warning Letter (drug product)

For suppliers

Is this Sofie?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.